Shilpa Medicare Joins Dr. Reddy's to Manufacture 5 Crore Doses of Sputnik V in a Year
Under the agreement, Shilpa Biologicals will be responsible for manufacturing the COVID-19 vaccine, while Dr. Reddy’s is responsible for the distribution/marketing of the vaccine in its marketing territories.
No comments:
Post a Comment